Response-adjusted α-interferon therapy for chronic hepatitis C in HIV-infected patients

International Journal of Antimicrobial Agents

Volumn 16, Issue 3, 2000, Pages 373-378

  Prestileo, Tullio ^a   Mazzola, Giovanni ^b   Di Lorenzo, Francesco ^a   Colletti, Piero ^b   Vitale, Francesco ^c   Ferraro, Donatella ^c   Di Stefano, Rosa ^c   Cammà, Calogero ^d   Crax, Antonio ^d,e  

^a Casa del Sole Hospital   (Italy)

^b Ospedale Guadagna   (Italy)

^c Dipartimento di Igiene e Microbiologia   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e Clinica Medica I   (Italy)

Author keywords

Interferon therapy; Hepatitis C; HIV infection

Indexed keywords

ALPHAN1 INTERFERON;

ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DISEASE COURSE; FATIGUE; FEMALE; FEVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MYALGIA; PRIORITY JOURNAL; RELAPSE; VIREMIA; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; MALE; PATIENT COMPLIANCE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0033727645     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00259-4     Document Type: Article

References (31)

1. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study
2. Natural history of liver fibrosis progression in patients with chronic hepatitis C
3. Hepatitis C in the patient with human immunodeficiency virus infection
4. The progression of HCV-associated liver disease in a cohort of haemophilic patients
5. Human immunodeficiency virus infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis
6. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
7. Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients
8. Hepatitis B and C in HIV-infected patients - Prevalence and prognostic value
9. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection
10. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
11. Interferons in HIV and related diseases
12. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C
13. Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients
14. Update. Trends in AIDS incidence
15. Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease
16. Lack of antiretroviral effect of alpha-interferon in HIV-infected patients treated for chronic hepatitis C
17. Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients
18. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV
19. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy
20. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune restoration disease
21. Consensus Statement - EASL International Consensus Conference on Hepatitis C, Paris 26-28 February
22. Consensus Development Conference Panel statement: Management of hepatitis C
23. A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients
24. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy
25. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
26. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis
27. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: Comparison between Amplicor HCV Monitor system and branched DNA signal amplification assay
28. Assessment of spontaneous fluctuations of viral load in untreated patients with chronic hepatitis C by two standardized quantitation methods: Branched DNA and Amplicor monitor
29. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C
30. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
31. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy